IDEX Corp

IDEX Corp(IEX)股票分析

$236.420

-2.175 (-0.92%)收盤時

Loading chart…
最高
241.300
開盤
239.000
成交量加權均價
237.19
成交量
766.54K
市值
15.15B
最低
233.840
成交金額
181.81M
企業價值/稅息折舊攤銷前利潤(TTM)
17.45

IDEX Corporation is a global applied solutions provider. The Company specializes in the manufacturing of health and science technologies, fluid and metering technologies, and fire, safety, and other diversified products. Its segments include Health & Science Technologies (HST), Fluid & Metering Technologies (FMT), and Fire & Safety/Diversified Products (FSDP). The HST segment designs, produces, and distributes a range of precision fluidics, positive displacement pumps, powder and liquid processing technologies, drying systems, micro-precision components, pneumatic components and sealing solutions. The FMT segment designs, produces, and distributes displacement pumps, valves, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems and provides flow monitoring and other services. The FSDP segment designs, produces, and distributes firefighting pumps, valves and controls, rescue tools, lifting bags and other components.

AI 分析 of IDEX Corp (IEX)

買進

IDEX Corp (IEX) is a good buy right now due to its strong financial performance, including a 30.84% year-to-date price increase and a robust gross margin of 46.36% in Q2 2026. Additionally, the stock's RSI is at 61.7, indicating positive momentum. The main risk is its current P/E ratio of 32.89, which suggests it may be overvalued if growth expectations are not met.

分析師評級(13)

-19.14% 下跌空間
持有
2 買進
11 持有
0 賣出
目前: 236.42
最低
170.00
平均
191.17
最高
202.00

Oppenheimer

2026-09-09

目標價

$270

優於大盤

Mizuho

2026-08-11

目標價

$280

優於大盤

DA Davidson

2026-08-06

目標價

$240

中性

Argus

2026-08-06

目標價

$260

買進

RBC Capital

2026-07-30

目標價

$280

優於大盤

估值指標

IDEX Corp(IEX)目前預期本益比為 23.98,5 年平均預期本益比為 25.00。

預期本益比

合理
5 年均值 P/E
25.00
目前P/E
23.98
高估
28.14
低估
21.86

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
17.87
目前EV/EBITDA
17.45
高估
19.72
低估
16.02

預期股價營收比

合理
5 年均值 P/S
4.62
目前P/S
4.49
高估
5.21
低估
4.03

Alphio AI 對 IEX 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%IEX

$218.02

情境價格

基

基準

基準 · 50%IEX

$207.60

情境價格

悲

悲觀

悲觀 · 25%IEX

$172.88

情境價格

持有 IEX 的大戶

M

Millennium Management LLC

+ 持有IEX

+10.05%

3個月報酬率

A

ASR Vermogensbeheer B.V.

+ 持有IEX

+5.10%

3個月報酬率

A

Alyeska Investment Group, L.P.

+ 持有IEX

+5.05%

3個月報酬率

F

Flossbach von Storch SE

+ 持有IEX

+4.74%

3個月報酬率

S

Snyder Capital Management, L.P.

+ 持有IEX

+4.53%

3個月報酬率

C

Champlain Investment Partners, LLC

+ 持有IEX

+4.06%

3個月報酬率

事件時間軸

2026-07-29 (ET)

07:30:00

Raises FY26 Organic Sales View to Increase 5%-6%

07:30:00

IDEX Reports Q2 Revenue of $921M, Exceeds Expectations

07:30:00

Q3 Organic Sales Projected to Increase 5% to 7%

2026-05-06 (ET)

14:00:00

Idex Corp. Announces Quarterly Cash Dividend Increase to 73 Cents

資訊

IEX 常見問題 —— 由 Alphio AI 解答

IDEX Corporation is a global applied solutions provider. The Company specializes in the manufacturing of health and science technologies, fluid and metering technologies, and fire, safety, and other diversified products. Its segments include Health & Science Technologies (HST), Fluid & Metering Technologies (FMT), and Fire & Safety/Diversified Products (FSDP). The HST segment designs, produces, and distributes a range of precision fluidics, positive displacement pumps, powder and liquid processing technologies, drying systems, micro-precision components, pneumatic components and sealing solutions. The FMT segment designs, produces, and distributes displacement pumps, valves, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems and provides flow monitoring and other services. The FSDP segment designs, produces, and distributes firefighting pumps, valves and controls, rescue tools, lifting bags and other components. It operates in the Industrials sector (PUMPS & PUMPING EQUIPMENT industry).

IDEX Corp (IEX) is a good buy right now due to its strong financial performance, including a 30.84% year-to-date price increase and a robust gross margin of 46.36% in Q2 2026. Additionally, the stock's RSI is at 61.7, indicating positive momentum. The main risk is its current P/E ratio of 32.89, which suggests it may be overvalued if growth expectations are not met.

13 analysts cover IEX: 2 rate it Buy, 11 Hold and 0 Sell. The average price target is 191.17.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易